Global report - March 21, 2025
AstraZeneca to invest USD 2.5 billion in R&D centre in Beijing
AstraZeneca is establishing a new global strategic R&D centre in Beijing, its second in China and sixth worldwide.
Global report - March 21, 2025
The changing US regulatory environment: Amid Chaos, Signs of Opportunity
Notwithstanding political ‘hiccups,’ the US will remain the most favored market for Nordic life science companies, say experts.
Global report - March 10, 2025
#IWD 2025: Accelerate Action, Leadership & Women in Life Sciences
The theme for International Women’s Day (IWD) 2025 is “Accelerate Action”. At the current rate of progress, it will take until 2158 to achieve full gender parity, according to the World Economic Forum.
Global report - March 7, 2025
Nobel laureates sign joint appeal for transfer of Russian sanctioned state assets
The Nobel Prize laureates protest against Russia's war of invasion and the world's inaction, and they demand that EUR 300 billion in frozen Russian assets be given to Ukraine.
Collaboration - February 12, 2025
Philanthropic partnership launches new initiative to tackle AMR
The Gates Foundation, Novo Nordisk Foundation, and Wellcome have announced the launch of the Gram-Negative Antibiotic Discovery Innovator (Gr-ADI), a USD 50 million investment that will focus on combatting antimicrobial resistance (AMR) caused by a specific range of bacteria that are among the leading contributors to AMR-associated deaths.
Collaboration - February 11, 2025
60+ European companies launch the ‘EU AI Champions Initiative’
All participants are determined to establish Europe as a global leader in Artificial Intelligence (AI), advancing AI development and application.
